Whole-genome sequence-based analysis of high-density lipoprotein cholesterol

Area of Science:

• Genetics
• Cardiovascular Research
• Genomic Epidemiology

Background:

• High-density lipoprotein cholesterol (HDL-C) is a complex trait influenced by genetic and environmental factors.
• Understanding the genetic architecture of HDL-C is crucial for developing targeted interventions for dyslipidemia and cardiovascular disease.
• Previous studies have focused on common variants, but the contribution of rare variants and non-coding regions remains less understood.

Purpose of the Study:

• To investigate the genetic architecture of high-density lipoprotein cholesterol (HDL-C) levels using whole-genome sequencing data.
• To compare the heritability contributions of common and rare genetic variations to HDL-C levels.
• To identify individuals with extreme HDL-C levels by screening for Mendelian variants associated with dyslipidemia.

Main Methods:

• Whole-genome sequencing of 962 individuals from the Cohorts for Heart and Aging Research in Genetic Epidemiology (CHARGE) studies.
• Analysis of genetic variation, including common and rare variants, across the genome.
• Screening for Mendelian variants related to dyslipidemia in individuals with extreme HDL-C levels.

Main Results:

• Common genetic variation contributes more significantly to the heritability of HDL-C levels than rare variation.
• Whole-genome sequencing analysis identified individuals with extreme HDL-C levels through screening for Mendelian variants.
• Regulatory and non-protein-coding regions of the genome play a notable role in HDL-C heritability, in addition to protein-coding regions.

Conclusions:

• Whole-genome sequencing provides valuable insights into the genetic basis of complex traits like HDL-C.
• Both common and rare genetic variations, as well as regulatory elements, are important for understanding HDL-C levels.
• Further research into non-coding and regulatory regions may uncover novel therapeutic targets for dyslipidemia.